Cargando…
Viral and atypical respiratory co‐infections in COVID‐19: a systematic review and meta‐analysis
OBJECTIVES: Respiratory co‐infections have the potential to affect the diagnosis and treatment of COVID‐19 patients. This meta‐analysis was performed to analyze the prevalence of respiratory pathogens (viruses and atypical bacteria) in COVID‐19 patients. METHODS: This review was consistent with Pref...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323310/ https://www.ncbi.nlm.nih.gov/pubmed/32838380 http://dx.doi.org/10.1002/emp2.12128 |
_version_ | 1783551767125950464 |
---|---|
author | Davis, Bennett Rothrock, Ava N. Swetland, Sarah Andris, Halle Davis, Phil Rothrock, Steven G. |
author_facet | Davis, Bennett Rothrock, Ava N. Swetland, Sarah Andris, Halle Davis, Phil Rothrock, Steven G. |
author_sort | Davis, Bennett |
collection | PubMed |
description | OBJECTIVES: Respiratory co‐infections have the potential to affect the diagnosis and treatment of COVID‐19 patients. This meta‐analysis was performed to analyze the prevalence of respiratory pathogens (viruses and atypical bacteria) in COVID‐19 patients. METHODS: This review was consistent with Preferred Reporting Items for Systematic reviews and Meta‐Analyses (PRISMA). Searched databases included: PubMed, EMBASE, Web of Science, Google Scholar, and grey literature. Studies with a series of SARS‐CoV‐2‐positive patients with additional respiratory pathogen testing were included. Independently, 2 authors extracted data and assessed quality of evidence across all studies using Cochrane's Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology and within each study using the Newcastle Ottawa scale. Data extraction and quality assessment disagreements were settled by a third author. Pooled prevalence of co‐infections was calculated using a random‐effects model with univariate meta‐regression performed to assess the effect of study subsets on heterogeneity. Publication bias was evaluated using funnel plot inspection, Begg's correlation, and Egger's test. RESULTS: Eighteen retrospective cohorts and 1 prospective study were included. Pooling of data (1880 subjects) showed an 11.6% (95% confidence interval [CI] = 6.9–17.4, I (2) = 0.92) pooled prevalence of respiratory co‐pathogens. Studies with 100% co‐pathogen testing (1210 subjects) found a pooled prevalence of 16.8% (95% CI = 8.1–27.9, I (2) = 0.95) and studies using serum antibody tests (488 subjects) found a pooled prevalence of 26.8% (95%, CI = 7.9–51.9, I (2) = 0.97). Meta‐regression found no moderators affecting heterogeneity. CONCLUSION: Co‐infection with respiratory pathogens is a common and potentially important occurrence in patients with COVID‐19. Knowledge of the prevalence and type of co‐infections may have diagnostic and management implications. |
format | Online Article Text |
id | pubmed-7323310 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73233102020-06-29 Viral and atypical respiratory co‐infections in COVID‐19: a systematic review and meta‐analysis Davis, Bennett Rothrock, Ava N. Swetland, Sarah Andris, Halle Davis, Phil Rothrock, Steven G. J Am Coll Emerg Physicians Open Infectious Disease OBJECTIVES: Respiratory co‐infections have the potential to affect the diagnosis and treatment of COVID‐19 patients. This meta‐analysis was performed to analyze the prevalence of respiratory pathogens (viruses and atypical bacteria) in COVID‐19 patients. METHODS: This review was consistent with Preferred Reporting Items for Systematic reviews and Meta‐Analyses (PRISMA). Searched databases included: PubMed, EMBASE, Web of Science, Google Scholar, and grey literature. Studies with a series of SARS‐CoV‐2‐positive patients with additional respiratory pathogen testing were included. Independently, 2 authors extracted data and assessed quality of evidence across all studies using Cochrane's Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology and within each study using the Newcastle Ottawa scale. Data extraction and quality assessment disagreements were settled by a third author. Pooled prevalence of co‐infections was calculated using a random‐effects model with univariate meta‐regression performed to assess the effect of study subsets on heterogeneity. Publication bias was evaluated using funnel plot inspection, Begg's correlation, and Egger's test. RESULTS: Eighteen retrospective cohorts and 1 prospective study were included. Pooling of data (1880 subjects) showed an 11.6% (95% confidence interval [CI] = 6.9–17.4, I (2) = 0.92) pooled prevalence of respiratory co‐pathogens. Studies with 100% co‐pathogen testing (1210 subjects) found a pooled prevalence of 16.8% (95% CI = 8.1–27.9, I (2) = 0.95) and studies using serum antibody tests (488 subjects) found a pooled prevalence of 26.8% (95%, CI = 7.9–51.9, I (2) = 0.97). Meta‐regression found no moderators affecting heterogeneity. CONCLUSION: Co‐infection with respiratory pathogens is a common and potentially important occurrence in patients with COVID‐19. Knowledge of the prevalence and type of co‐infections may have diagnostic and management implications. John Wiley and Sons Inc. 2020-06-19 /pmc/articles/PMC7323310/ /pubmed/32838380 http://dx.doi.org/10.1002/emp2.12128 Text en © 2020 The Authors. JACEP Open published by Wiley Periodicals LLC on behalf of the American College of Emergency Physicians. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Infectious Disease Davis, Bennett Rothrock, Ava N. Swetland, Sarah Andris, Halle Davis, Phil Rothrock, Steven G. Viral and atypical respiratory co‐infections in COVID‐19: a systematic review and meta‐analysis |
title | Viral and atypical respiratory co‐infections in COVID‐19: a systematic review and meta‐analysis |
title_full | Viral and atypical respiratory co‐infections in COVID‐19: a systematic review and meta‐analysis |
title_fullStr | Viral and atypical respiratory co‐infections in COVID‐19: a systematic review and meta‐analysis |
title_full_unstemmed | Viral and atypical respiratory co‐infections in COVID‐19: a systematic review and meta‐analysis |
title_short | Viral and atypical respiratory co‐infections in COVID‐19: a systematic review and meta‐analysis |
title_sort | viral and atypical respiratory co‐infections in covid‐19: a systematic review and meta‐analysis |
topic | Infectious Disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323310/ https://www.ncbi.nlm.nih.gov/pubmed/32838380 http://dx.doi.org/10.1002/emp2.12128 |
work_keys_str_mv | AT davisbennett viralandatypicalrespiratorycoinfectionsincovid19asystematicreviewandmetaanalysis AT rothrockavan viralandatypicalrespiratorycoinfectionsincovid19asystematicreviewandmetaanalysis AT swetlandsarah viralandatypicalrespiratorycoinfectionsincovid19asystematicreviewandmetaanalysis AT andrishalle viralandatypicalrespiratorycoinfectionsincovid19asystematicreviewandmetaanalysis AT davisphil viralandatypicalrespiratorycoinfectionsincovid19asystematicreviewandmetaanalysis AT rothrocksteveng viralandatypicalrespiratorycoinfectionsincovid19asystematicreviewandmetaanalysis |